Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Opticgon LLC operates within the Medical Devices & Mechanical Engineering technology area, where it currently faces 2 pending office actions. These actions are distributed among 2 distinct examiners, indicating a diversified review process for the company's intellectual property. Furthermore, the portfolio is active across 2 distinct art units, which suggests that the underlying technologies may span different specialized classifications within the broader engineering field.
LYNCH, ROBERT A is the busiest examiner for Opticgon LLC, currently managing 1 pending office action. This means that the 2 pending office actions are split, with 1 action assigned to the busiest examiner and the remaining action assigned to another distinct examiner. This distribution across 2 distinct art units and 2 distinct examiners requires a multi-faceted prosecution strategy, as the company must address the specific requirements of different reviewers simultaneously. The fact that the busiest examiner handles 1 pending office action out of a total of 2 shows that no single examiner dominates the current workload.
Practitioners should prepare for varied feedback across the 2 distinct art units to ensure protection for their medical and mechanical innovations. Analyzing the specific history of LYNCH, ROBERT A will be important for the 1 pending office action he oversees. This approach will be necessary to manage the 2 pending office actions effectively within the Medical Devices & Mechanical Engineering sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 2 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LYNCH, ROBERT A | 1 | 80.3% | +12.9% |
| MALATEK, KATHERYN A | 1 | 86.7% | +43.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18501879 | SURGICAL INSTRUMENT WITH GUARDED BLADE | LYNCH, ROBERT A | 14d |
| 18374304 | SURGICAL TOOL FOR TRANSRETINAL PNEUMATIC DISPLACEMENT OF SUB-RETINAL HEMORRHAGE | MALATEK, KATHERYN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18501879 | SURGICAL INSTRUMENT WITH GUARDED BLADE | LYNCH, ROBERT A | 14d |
| 18374304 | SURGICAL TOOL FOR TRANSRETINAL PNEUMATIC DISPLACEMENT OF SUB-RETINAL HEMORRHAGE | MALATEK, KATHERYN A | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 3741 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18501879 | SURGICAL INSTRUMENT WITH GUARDED BLADE | LYNCH, ROBERT A | 3771 | §102§103§112 | Non-Final OA | 14d | Pending | Nov 03, 2023 |
| 18374304 | SURGICAL TOOL FOR TRANSRETINAL PNEUMATIC DISPLACEMENT OF SUB-RETINAL HEMORRHAGE | MALATEK, KATHERYN A | 3741 | §103§112 | Non-Final OA | — | Pending | Sep 28, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial